The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 12, 2019
Filed:
May. 16, 2016
Applicant:
Revance Therapeutics, Inc., Newark, CA (US);
Inventors:
Curtis L. Ruegg, Redwood City, CA (US);
Hongran Fan Stone, Beijing, CN;
Jacob M. Waugh, Palo Alto, CA (US);
Assignee:
Revance Therapeutics, Inc., Newark, CA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/08 (2006.01); A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/34 (2017.01); A61K 47/42 (2017.01); A61M 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4893 (2013.01); A61K 9/0043 (2013.01); A61K 38/48 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); A61K 47/42 (2013.01); A61M 31/00 (2013.01); C12Y 304/24069 (2013.01);
Abstract
Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purifiedneurotoxin, a carrier and a viscosity modifier to one or more inner surfaces of the nose. The methods disclosed herein provide alternative methods for delivery ofneurotoxin to the nasal anatomy for the treatment of rhinitis.